Bio / Pharma
Yuhan's Leclaza Approved in 7 Countries in a Year
Yuhan Corporation's 'Leclaza,' the first domestic anticancer drug to break through the U.S. Food and Drug Administration (FDA) barrier, has received sales approval in seven countries, including South Korea, the United States, Europe, the United Kingdom, Japan, Canada, and China, just one year after
2025.08.19
About Dong-A Ilbo